The use of a long-acting sub-cutaneous insulin analogue in the management of hyperglycaemic emergencies

Trial Profile

The use of a long-acting sub-cutaneous insulin analogue in the management of hyperglycaemic emergencies

Withdrawn prior to enrolment
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 15 May 2007

At a glance

  • Drugs Insulin detemir (Primary)
  • Indications Diabetic ketoacidosis; Hyperglycaemic hyperosmolar nonketotic coma
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top